Beta-hydroxybutyrate / Exogenous Ketones for Cognitive Function

Verdict: Unverified for cognition; evidence too thin

There is no reliable evidence that beta-hydroxybutyrate or other exogenous ketone supplements improve cognitive function in healthy adults. The few human trials are small, short, and inconsistent, so this use remains unverified rather than proven.

U ⚫ U Unverified Taiwan Regulatory Restriction

🔬Why this grade7-layer evidence engine

The human trials are sparse and weak. A small acute crossover RCT raised blood BHB above 2 mmol/L but found no consistent cognitive benefit versus placebo (PMID 34605026). The only positive signals came from MCT-based ketogenic regimens in Alzheimer's (PMID 30367958) and mild cognitive impairment (PMID 33103819), small pilot studies in patients, not BHB supplements in healthy people. A 2025 systematic review concluded the evidence is limited and heterogeneous, with cognitive benefits inconsistent in healthy adults (PMID 41001501).

Regulators and clinics do not endorse this use. The US FDA's 'no questions' GRAS responses cover food safety only, not cognitive efficacy, and EFSA found the safety of BHB salts as a novel food not established, with no authorised cognition claims. NHS and WHO have not addressed it. Harvard Health states there are no human studies supporting ketosis for brain disorders, and the Alzheimer's Association says no supplement has been proven to benefit cognitive function or brain health.

The grade is Unverified because the evidence gap is structural, not merely preliminary: no adequately powered, long-term RCT tests BHB-only supplements on cognition in healthy adults, and benefit signals are confined to MCT-based protocols in disease populations that cannot be extrapolated. A drug-interaction flag (notably with diabetes medications) adds caution. The honest conclusion is that it does not have demonstrated cognitive benefit.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.42
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Taiwan Regulatory Restriction
Confidence
71%
Broadly consistent
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.20
L5 Clinical bodiesAuthoritative stance
0.40
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.418
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Short-term ketone monoester supplementation improves cerebral blood flow and cognition in obesity: A randomized cross-over trial
PMID: 34605026 2021 隨機對照試驗 n = 12
Finding: Plasma BHB rose markedly (>2 mmol/L) but no consistent improvement in cognitive performance versus placebo; some task-specific signals only.
🟠 Limited quality
View on PubMed
Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease
PMID: 30367958 2019 隨機對照試驗 n = 26
Finding: Modest improvement on ADAS-Cog in treatment arm vs control over 12 weeks; small pilot with high attrition limits firm conclusions.
🟠 Limited quality
View on PubMed
A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT
PMID: 33103819 2020 隨機對照試驗 n = 39
Finding: Treatment arm showed improvement in episodic memory and executive function correlated with brain ketone uptake; pilot scale, not definitive.
Academic
View on PubMed
The Effect of Exogenous Ketone Bodies on Cognition in Patients with Mild Cognitive Impairment, Alzheimer's Disease and in Healthy Adults: A Systematic Review and Meta-Analysis
PMID: 41001501 2025 系統性回顧
Finding: Evidence is limited and heterogeneous; acute ketone ingestion reliably raises BHB but cognitive benefits are inconsistent in healthy adults; signals of benefit appear mainly in MCI/AD with sustained MCT-based regimens.
Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
FDA has no questions source↗
L4b EU EFSA
Cautious
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Cautious
you may think more clearly and notice appetite suppression when taking ketone supplements source↗
L5d Harvard Health
Cautious
Because of these neuroprotective effects, questions have been raised about the possible benefits for other brain disorders such as Parkinson's, Alzheimer's, multiple sclerosis, sleep disorders, autism, and even brain cancer. However, there are no human studies to support recommending ketosis to treat these conditions. source↗
L5e Specialty Society (condition-mapped)
Cautious
not a single food, beverage, ingredient, vitamin or supplement has been proven to prevent, treat or cure Alzheimer's disease or to benefit cognitive function or brain health. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-beta-hydroxybutyrate-001 繁體中文版 →